Back
Novo Nordisk AS Stock Predictions
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
37
NONOF
Novo Nordisk AS
Last Price:
$65.14
Seasonality Move:
4.38%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Novo Nordisk AS Stock Forecast
-
Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 22% based on the past 16 years of stock performance.
-
Novo Nordisk AS has risen higher in 12 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Novo Nordisk AS Stock Undervalued?The current Novo Nordisk AS [NONOF] share price is $65.14. The Score for NONOF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk AS Stock Go Up Next Year?
-
Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 22% based on the past 16 years of stock performance.
Novo Nordisk AS Stock Rating
Sell
37
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS overpriced?
-
Novo Nordisk AS has risen higher in 12 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Novo Nordisk AS Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
149.55
52-Week Low:
55.28
Prediction Charts
Market Cap:
289.4B
Price in USD:
65.14
Volume:
21.2K
Beta:
0.55
Technical Analysis
SMA50:
70.80
SMA100:
78.83
SMA200:
99.84
52-Wk Change:
-49%
Stock Predictions
-
Is Novo Nordisk AS stock public?Yes, Novo Nordisk AS is a publicly traded company.
-
What is the Novo Nordisk AS stock quote today?The Novo Nordisk AS stock price is 65.14 USD today.
-
How to buy Novo Nordisk AS stock online?You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-22 | 58.18 | 61.00 | 62.07 | 55.28 |
| Apr-23 | 63.72 | 61.50 | 63.72 | 59.90 |
| Apr-24 | 62.46 | 61.55 | 64.39 | 61.13 |
| Apr-25 | 60.77 | 62.25 | 63.74 | 60.38 |
| Apr-28 | 61.16 | 61.16 | 63.75 | 60.98 |
| Apr-29 | 63.75 | 67.00 | 67.78 | 61.93 |
| Apr-30 | 62.49 | 67.40 | 67.99 | 62.49 |
| May-1 | 68.77 | 65.50 | 71.24 | 64.00 |
| May-2 | 69.60 | 68.40 | 71.63 | 68.01 |
| May-5 | 66.90 | 68.24 | 71.44 | 66.90 |
| May-6 | 63.10 | 66.23 | 69.28 | 63.10 |
| May-7 | 71.52 | 66.00 | 71.64 | 66.00 |
| May-8 | 66.49 | 64.00 | 67.19 | 63.33 |
| May-9 | 66.40 | 65.14 | 69.20 | 65.14 |
Novo Nordisk AS Earnings
Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk AS Forecast Revenue Growth
Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.